MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Osiris Therapeutics Company Profile (NASDAQ:OSIR)

Consensus Ratings for Osiris Therapeutics (NASDAQ:OSIR) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $16.00 (140.24% upside)

Analysts' Ratings History for Osiris Therapeutics (NASDAQ:OSIR)
Show:
DateFirmActionRatingPrice TargetActions
2/4/2016Brean CapitalReiterated RatingSell$8.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Brean CapitalReiterated RatingSell$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/30/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015Piper JaffrayReiterated RatingBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015Brean CapitalDowngradeHold -> Sell$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/1/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015Brean CapitalInitiated CoverageBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Brean CapitalBoost Price TargetBuy$19.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015Brean CapitalReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Brean CapitalSet Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Brean CapitalSet Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2014Brean CapitalInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014R. F. LaffertyInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha